HIC
BLUE

Holderness Investments Company’s bluebird bio BLUE Stock Holding History

Holderness Investments Company’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-796
Closed -$8.27K – 256
2024
Q3 		$8.27K Sell
796
-208
-21% -$3.46K ﹤0.01% 256
2024
Q2 		$19.8K Hold
1,004
– – ﹤0.01% 239
2024
Q1 		$25.7K Hold
1,004
– – 0.01% 246
2023
Q4 		$27.7K Buy
1,004
+2
+0.2% +$122 0.01% 234
2023
Q3 		$60.9K Sell
1,002
-30
-3% -$2.11K 0.02% 192
2023
Q2 		$67.9K Buy
1,032
+7
+0.7% +$512 0.03% 199
2023
Q1 		$65.2K Buy
1,025
+88
+9% +$10.1K 0.03% 198
2022
Q4 		$130K Buy
937
+168
+22% +$23.7K 0.06% 187
2022
Q3 		$97K Buy
+769
New +$87K 0.04% 187
2021
Q3 		– Sell
-514
Closed -$213K – 217
2021
Q2 		$213K Buy
+514
New +$204K 0.07% 209

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Holderness Investments Company's BLUE Position: Q4 2024 in Review

Holderness Investments Company sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 796 shares — an estimated $8.27K sold.

Holderness Investments Company first reported a position in BLUE in Q2 2021 and held it in 10 quarters. The position peaked at $213K in Q2 2021. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Holderness Investments Company reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Holderness Investments Company sold 796 bluebird bio shares in Q4 2024, an estimated $8.27K.
  • Holderness Investments Company first reported a position in bluebird bio in Q2 2021 and held it in 10 quarters.
  • Holderness Investments Company's bluebird bio position peaked at $213K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Holderness Investments Company's 13F filing for Q4 2024, filed 11 Feb 2025.